Pubblicazioni

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review

2022 - FRONTIERS IN ONCOLOGY
Rizzo, S.; Raia, G.; Del Grande, M.; Gasparri, M. L.; Colombo, I.; Manganaro, L.; Papadia, A.; Del Grande, F.

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

2022 - FRONTIERS IN ONCOLOGY
Rundo, L.; Beer, L.; Escudero Sanchez, L.; Crispin-Ortuzar, M.; Reinius, M.; Mccague, C.; Sahin, H.; Bura, V.; Pintican, R.; Zerunian, M.; Ursprung, S.; Allajbeu, I.; Addley, H.; Martin-Gonzalez, P.; Buddenkotte, T.; Singh, N.; Sahdev, A.; Funingana, I. -G.; Jimenez-Linan, M.; Markowetz, F.; Brenton, J. D.; Sala, E.; Woitek, R.

Computed Tomography–Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis

2021 - FRONTIERS IN ONCOLOGY
Del Grande, M.; Rizzo, S.; Nicolino, G. M.; Colombo, I.; Rossi, L.; Manganaro, L.; Del Grande, F.

The controversial role of PD-1 and its ligands in gynecological malignancies

2019 - FRONTIERS IN ONCOLOGY
Marinelli, O.; Annibali, D.; Aguzzi, C.; Tuyaerts, S.; Amant, F.; Morelli, M. B.; Santoni, G.; AMANTINI, Consuelo; MAGGI, FEDERICA; Nabissi, M.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma